Key result
Three-factor PCC effectively reverses emergency oral anticoagulation to mean INR <2.0 despite frequent guideline deviations.
Why the study?
Does three-factor prothrombin complex concentrate effectively and safely reverse oral anticoagulation in patients with critical bleeding or requiring emergency surgery?
Observational (n=47)
No
Does three-factor prothrombin complex concentrate effectively and safely reverse oral anticoagulation in patients with critical bleeding or requiring emergency surgery?
Three-factor prothrombin complex concentrates effectively and safely reduced INR in patients requiring emergency reversal of oral anticoagulation, though real-world hospital protocols often deviated from established guidelines.
Answers are grounded in this paper and cite their sources.
Retrospective audit of PCC for OAT reversal highlights potential guideline gaps; leaves open need for standardized protocols and prospective outcome data.
BACKGROUND: Prothrombin Complex Concentrates (PCC) are administered to normalise blood coagulation in patients receiving oral anticoagulant therapy (OAT). Rapid reversal of OAT is essential in case of major bleeding, internal haemorrhage or surgery.The primary end-point was to evaluate whether PCC in our hospital were being used in compliance with international and national guidelines for the reversal of OAT on an emergency basis. The secondary end-point was to evaluate the efficacy and safety of PCC. MATERIALS AND METHODS: All patients receiving OAT who required rapid reversal anticoagulation because they had to undergo emergency surgery or urgent invasive techniques following an overdose of oral anticoagulants were eligible for this retrospective observational study. RESULTS: Forty-seven patients receiving OAT who needed rapid reverse of anticoagulation were enrolled in our study. The patients were divided in two groups: (i) group A (n=23), patients needed haemostatic treatment before neurosurgery after a head injury and (ii) group B (n=24), patients with critical haemorrhage because of an overdose of oral anticoagulants. The International Normalised Ratio (INR) was checked before and after infusion of the PCC. The mean INR in group A was 2.7 before and 1.43 after infusion of the PCC; in group B the mean INR of 6.58, before and 1.92 after drug infusion. The use of vitamin K, fresh-frozen plasma and red blood cells was also considered. During our study 22 patients died, but no adverse effects following PCC administration were recorded. DISCUSSION: In our study three-factor-PCC was found to be effective and safe in rapidly reversing the effects of OAT, although it was not always administered in accordance with international or national guidelines. The dose, time of administration and monitoring often differed from those recommended. In the light of these findings, we advocate the use of single standard protocol to guide the correct use of PCC in each hospital ward.
No takes yet. Share an insight, caveat, or question.
Barillari et al. (2012) conducted an observational in Patients receiving oral anticoagulant therapy requiring rapid reversal due to emergency surgery or critical hemorrhage (n=47). Prothrombin complex concentrates (PCC) vs. None (before-after comparison) was evaluated on Compliance with international and national guidelines for emergency reversal of oral anticoagulation, and efficacy in reducing INR. Three-factor prothrombin complex concentrates effectively reversed oral anticoagulation in emergencies, reducing mean INR to <2.0, despite frequent deviations from administration guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: